Stock listing
Adc Therapeutics Sa
Selected listing: ADCT · NYSE · USD · US
Adc Therapeutics Sa (NYSE:ADCT), Health Technology. Latest release Sep 3, 2026: ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference.
- Ticker
- NYSE:ADCT
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NYSE
- Currency
- USD
About Adc Therapeutics Sa
Adc Therapeutics SA is a public company traded under the ticker ADCT in the American market. Adc Therapeutics focuses on developing targeted therapies for patients with hematologic malignancies and solid tumors.
Latest news from Adc Therapeutics Sa
ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
September 3, 2026
ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates
August 13, 2026
ADC Therapeutics to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026
August 6, 2026
ADC Therapeutics Announces Completion of Enrollment in LOTIS-7 Phase 1b ZYNLONTA® Combination Trial
June 30, 2026
ADC Therapeutics Announces Strategic Reorganization to Support ZYNLONTA® Growth Opportunities and Regulatory Priorities
June 24, 2026